Poland· PL-100217386
Spiriva Respimat
A tiotropium bromide product containing tiotropium, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tiotropium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BB04 (tiotropium bromide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Tiotropium bromide · ATC R03BB04
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of tiotropium bromide costs, country by country.
Normalised to the WHO defined daily dose (5 mcg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tiotropium bromide · price per daily dose (5 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$0.50
- IT Italy$0.34
The record
At a glance
URPL (Poland)- Active substance
- Tiotropium
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Poland (PL)
- ATC code
- R03BB04
- ATC class
- Tiotropium bromide
- Defined daily dose
- 5 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
1 priced- gtin059099907358391 wkł. 30 dawek leczniczych (60 dawek odmierzonych) + 1 inhalator RespimatPLN 118.66
- gtin05909991432065
- gtin05909991432072
- gtin05909991432089
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
510 interactions on record for tiotropium bromide.
Graded by severity as the source publishes them — 113 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiotropium bromide · interactions on record
510 records
- 113 moderate
- 2 minor
- 395 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tiotropium bromide in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSpiriva Respimat 2.5micrograms/dose inhalation solution cartridge with deviceBoehringer Ingelheim Ltd
- FinlandSpiriva RespimatBoehringer Ingelheim International GmbH
- IrelandSpiriva Respimat 2.5 microgram inhalation solutionIMED Healthcare Ltd.,
- NetherlandsSpiriva Respimat 2,5 microgram, inhalatieoplossingBoehringer Ingelheim International GmbH
- SwitzerlandSpiriva Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)Boehringer Ingelheim (Schweiz) GmbH
- SwedenSpiriva Respimat 2,5 mikrogram per puff Inhalationsvätska, lösningBoehringer Ingelheim International GmbH
- CanadaSPIRIVA RESPIMATBOEHRINGER INGELHEIM (CANADA) LTD LTEE
- SpainSPIRIVA RESPIMAT 2,5 microgramos SOLUCION PARA INHALACIONBoehringer Ingelheim International Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Braltus, Spiriva
- Belgium · Spiriva, Spiriva Respimat
- Bulgaria · Бралтус, Плубром
- Cyprus · Spiriva, Spiriva Respimat
- Czechia · Gartior, Spiriva
- Germany · Acopair, Braltus
- Denmark · Braltus, Spiriva
- Estonia · Spiriva Respimat
- Spain · Braltus, Gregal
- Finland · Spiriva, Spiriva Respimat
- France · Spiriva, Spiriva Respimat
- United Kingdom (Northern Ireland) · Abtio, Acopair
- Greece · Spiriva, Spiriva Respimat
- Croatia · Acopair, Braltus
- Hungary · Braltus, Ontipria
- Ireland · Braltus, Spiriva
- Iceland · Braltus, Spiriva
- Italy · Scinorus, Sirkava
- Liechtenstein · Spiriva, Spiriva Respimat
- Lithuania · Spiriva, Spiriva Respimat
- Luxembourg · Spiriva, Spiriva Respimat
- Latvia · Spiriva, Spiriva Respimat
- Malta · Spiriva, Spiriva Respimat
- Netherlands · Scinorus, Spiriva
- Norway · Braltus, Spiriva
- Portugal · Braltus, Brometo De Tiotrópio Stada
- Romania · Dilochob, Gregal
- Sweden · Braltus, Sirkava
- Slovenia · Spiriva, Spiriva Respimat
- Slovakia · Spiriva, Spiriva Respimat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/745f404e-d15e-44c9-a6b5-27da0ffd9526 GET /v1/drugs/745f404e-d15e-44c9-a6b5-27da0ffd9526?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do inhalacji",
"source": "urpl",
"strength": "2,5 mcg/dawkę odmierzoną",
"packaging": "05909990735839 ¦ Rp ¦ 41676\n1 wkład 30 dawek leczniczych ¦ 1 inhalator Respimat\n05909991432065 ¦ Rp ¦ 136682\n1 wkład 30 dawek leczniczych\n05909991432072 ¦ Rp ¦ 136683\n3 wkłady 30 dawek leczniczych ¦ 1 inhalator Respimat\n05909991432089 ¦ Rp ¦ 136684\n3 wkłady 30 dawek leczniczych",
"substance": "Tiotropii bromidum monohydricum 3.124 mcg",
"common_name": "Tiotropium",
"pl_product_id": "100217386",
"pozwolenie_nr": "16125",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about tiotropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.